N/A N=60 Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound
Treatment of Adipose Tissue in the Thighs
Primary: Clinical Improvement in Thigh Circumference — -1.22; -0.59 centimeter
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=20 Autologous, Micro-fragmented Adipose Tissue for Meniscal Tears
Tibial Meniscus Injuries · Osteoarthritis, Knee
Primary: Change in Numerical Pain Scale — -3.2 units on a scale
Phase 4 N=20 Angiotensin II Blockade and Inflammation in Obesity
Overweight · Obese · Prehypertension
Primary: Insulin Sensitivity by Intravenous Glucose Tolerance Testing (Change Over Time) — 0.253; -0.804 mu/L/min
Phase 4 N=29 Fish Oils and Adipose Inflammation Reduction
Obesity
Primary: Change in Plasma Fractalkine Levels — 0.42; 0.46; 0.48; 0.45 ng/ml
Phase 4 N=45 Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir
HIV Seropositivity · Metabolic Syndrome · Fatty Liver
Primary: Change in Liver Fat — 0.3; 0.6 % hepatic fat fraction
N/A N=71 Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial
Osteoarthritis, Knee · Microfragmented Adipose Tissue · Platelet-Rich Plasma
Primary: KOOS Pain [Knee Injury and Osteoarthritis Outcome Score] — 79.95; 77.78 units on a scale — p=0.69
N/A N=96 Glucose and Lipid Metabolism on Antipsychotic Medication
Schizophrenia · Schizoaffective Disorder · Type 2 Diabetes Mellitus
Primary: DEXA Total Fat — 32.24; 27.66; 28.83; 31.60 kilograms of body fat — p=0.002
Phase 2 N=17 MIrabegron and Physiological Function in Cold Environments
Resting Energy Expenditure · Thermogenesis · Brown Adipose Tissue
Primary: Cold Temperature Deflection Point — 22.8; 22.97 degrees Celsius
N/A N=5 Sympathetic Activation in Obesity
Obesity · Healthy
Primary: Distribution Volume Ratio (DVR) of [11C]MRB PET Imaging of Peripheral Sympathetic Nervous System — 0.13; -0.025; 0.095; -0.03 DVR
N/A N=69 Brown Adipose Tissue Activity in Pre- and Postmenopausal Women
Menopause · Obesity
Primary: Brown Adipose Tissue Volume — 53.1; 20.6 mL
Phase 2 N=30 Mirabegron and Physiological Function in Cold Environments
Resting Energy Expenditure · Thermogenesis · Brown Adipose Tissue
Primary: Cumulative Resting Energy Expenditure — 456.4; 494.7; 481.3; 492.8 kcal
N/A N=80 Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
Chronic Kidney Disease · Diabetes
Primary: Change in Thiobarbituric Acid Reactive Substance (TBARS) Concentration in Adipose Tissue From Baseline to 24 Weeks — 34.0; 44.6 percent difference in geometric mean…
N/A N=100 Adipocytokines in Endometrial Cancer
Endometrial Cancer · Obesity
Primary: Correlation Between Circulating Levels of These Markers and Demographic Characteristics. — 39; 42; 11; 8 Participants — p=0.026
Phase 3 N=326 Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients
HIV Infections · Lipodystrophy
Primary: Treatment Period I: Change From Baseline in Absolute Area of Visceral Adipose Tissue (VAT) at Week 12 — 0.5; -32.6 Square Centimeter (cm^2) — p=<0.001
Phase 4 N=14 A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device for the Appearance of Cellulite in Adult Participants
Cellulite
Primary: Percentage of Before and After Side-by-side Photographs Correctly Identified by At Least 2 of 3 Blinded Reviewers From the Independent Physician Reviewer (IPR) Panel…